Annual Retained Earnings
-$17.49 M
-$6.28 M-56.02%
31 December 2023
Summary:
Cumberland Pharmaceuticals annual retained earnings is currently -$17.49 million, with the most recent change of -$6.28 million (-56.02%) on 31 December 2023. During the last 3 years, it has fallen by -$11.85 million (-210.15%). CPIX annual retained earnings is now -189.46% below its all-time high of $19.55 million, reached on 31 December 2015.CPIX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$22.06 M
-$1.54 M-7.52%
30 September 2024
Summary:
Cumberland Pharmaceuticals quarterly retained earnings is currently -$22.06 million, with the most recent change of -$1.54 million (-7.52%) on 30 September 2024. Over the past year, it has dropped by -$4.58 million (-26.17%). CPIX quarterly retained earnings is now -212.86% below its all-time high of $19.55 million, reached on 31 December 2015.CPIX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPIX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -26.2% |
| 3 y3 years | -210.2% | -291.3% |
| 5 y5 years | -1547.2% | -1925.9% |
CPIX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -720.7% | at low | -1132.0% | at low |
| 5 y | 5 years | -468.5% | at low | -1117.2% | at low |
| alltime | all time | -189.5% | at low | -212.9% | at low |
Cumberland Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$22.06 M(+7.5%) |
| June 2024 | - | -$20.52 M(+5.6%) |
| Mar 2024 | - | -$19.43 M(+11.1%) |
| Dec 2023 | -$17.49 M(+56.0%) | -$17.49 M(+56.2%) |
| Sept 2023 | - | -$11.19 M(+10.3%) |
| June 2023 | - | -$10.14 M(-7.9%) |
| Mar 2023 | - | -$11.02 M(-1.7%) |
| Dec 2022 | -$11.21 M(+98.8%) | -$11.21 M(+27.8%) |
| Sept 2022 | - | -$8.77 M(+4.9%) |
| June 2022 | - | -$8.36 M(+19.0%) |
| Mar 2022 | - | -$7.02 M(+24.6%) |
| Dec 2021 | -$5.64 M(+164.6%) | -$5.64 M(+214.8%) |
| Sept 2021 | - | -$1.79 M(+143.5%) |
| June 2021 | - | -$735.60 K(-62.5%) |
| Mar 2021 | - | -$1.96 M(-7.8%) |
| Dec 2020 | -$2.13 M(-276.3%) | -$2.13 M(+70.9%) |
| Sept 2020 | - | -$1.25 M(+62.9%) |
| June 2020 | - | -$765.50 K(-601.0%) |
| Mar 2020 | - | $152.80 K(-87.4%) |
| Dec 2019 | $1.21 M(-74.5%) | $1.21 M(-44.3%) |
| Sept 2019 | - | $2.17 M(-47.4%) |
| June 2019 | - | $4.12 M(-11.8%) |
| Mar 2019 | - | $4.67 M(-1.6%) |
| Dec 2018 | $4.75 M(-59.5%) | $4.75 M(-31.9%) |
| Sept 2018 | - | $6.97 M(-19.1%) |
| June 2018 | - | $8.61 M(-7.7%) |
| Mar 2018 | - | $9.33 M(-20.3%) |
| Dec 2017 | $11.71 M(-37.1%) | $11.71 M(-6.4%) |
| Sept 2017 | - | $12.51 M(-5.6%) |
| June 2017 | - | $13.25 M(-28.0%) |
| Mar 2017 | - | $18.41 M(-1.0%) |
| Dec 2016 | $18.60 M(-4.8%) | $18.60 M(-3.9%) |
| Sept 2016 | - | $19.35 M(+0.6%) |
| June 2016 | - | $19.25 M(-0.2%) |
| Mar 2016 | - | $19.30 M(-1.3%) |
| Dec 2015 | $19.55 M | $19.55 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $19.40 M(+0.7%) |
| June 2015 | - | $19.27 M(+2.2%) |
| Mar 2015 | - | $18.86 M(+0.2%) |
| Dec 2014 | $18.82 M(+14.8%) | $18.82 M(+3.7%) |
| Sept 2014 | - | $18.15 M(+4.3%) |
| June 2014 | - | $17.40 M(+4.3%) |
| Mar 2014 | - | $16.68 M(+1.7%) |
| Dec 2013 | $16.39 M(-11.4%) | $16.39 M(-8.4%) |
| Sept 2013 | - | $17.89 M(-4.4%) |
| June 2013 | - | $18.71 M(-3.3%) |
| Mar 2013 | - | $19.35 M(+4.6%) |
| Dec 2012 | $18.50 M(+46.2%) | $18.50 M(+10.8%) |
| Sept 2012 | - | $16.69 M(+12.6%) |
| June 2012 | - | $14.82 M(+13.3%) |
| Mar 2012 | - | $13.08 M(+3.3%) |
| Dec 2011 | $12.66 M(+80.8%) | $12.66 M(+7.8%) |
| Sept 2011 | - | $11.74 M(+18.7%) |
| June 2011 | - | $9.90 M(+28.2%) |
| Mar 2011 | - | $7.72 M(+10.3%) |
| Dec 2010 | $7.00 M(+54.1%) | $7.00 M(+13.6%) |
| Sept 2010 | - | $6.16 M(+19.6%) |
| June 2010 | - | $5.15 M(+5.9%) |
| Mar 2010 | - | $4.87 M(+7.1%) |
| Dec 2009 | $4.54 M(+213.1%) | $4.54 M(+6.8%) |
| Sept 2009 | - | $4.25 M(+43.4%) |
| June 2009 | - | $2.96 M(+11.1%) |
| Mar 2009 | - | $2.67 M(+84.0%) |
| Dec 2008 | $1.45 M(-143.8%) | $1.45 M(+317.9%) |
| Sept 2008 | - | $347.10 K(-140.3%) |
| June 2008 | - | -$861.90 K(-55.1%) |
| Mar 2008 | - | -$1.92 M(-42.1%) |
| Dec 2007 | -$3.32 M(-55.0%) | -$3.32 M(-19.7%) |
| Sept 2007 | - | -$4.13 M(-23.1%) |
| June 2007 | - | -$5.37 M(-18.9%) |
| Mar 2007 | - | -$6.62 M(-10.0%) |
| Dec 2006 | -$7.36 M(-37.4%) | -$7.36 M |
| Dec 2005 | -$11.76 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly retained earnings year-on-year change?
What is Cumberland Pharmaceuticals annual retained earnings?
The current annual retained earnings of CPIX is -$17.49 M
What is the all time high annual retained earnings for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual retained earnings is $19.55 M
What is Cumberland Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CPIX is -$22.06 M
What is the all time high quarterly retained earnings for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly retained earnings is $19.55 M
What is Cumberland Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CPIX quarterly retained earnings has changed by -$4.58 M (-26.17%)